cDNA cloning

DB Daniela A. Braun
CS Carolin E. Sadowski
SK Stefan Kohl
SL Svjetlana Lovric
SA Susanne A. Astrinidis
WP Werner L. Pabst
HG Heon Yung Gee
SA Shazia Ashraf
JL Jennifer A. Lawson
SS Shirlee Shril
MA Merlin Airik
WT Weizhen Tan
DS David Schapiro
JR Jia Rao
WC Won-Il Choi
TH Tobias Hermle
MK Markus J. Kemper
MP Martin Pohl
FO Fatih Ozaltin
MK Martin Konrad
RB Radovan Bogdanovic
RB Rainer Büscher
UH Udo Helmchen
ES Erkin Serdaroglu
RL Richard P. Lifton
WA Wolfram Antonin
FH Friedhelm Hildebrandt
request Request a Protocol
ask Ask a question
Favorite

Human NUP93 full-length cDNA was subcloned by PCR from human full-length cDNA (cDNA clone MGC: 21106 IMAGE: 4750923). Mouse NUP93 was subcloned from mouse NUP93 full-length cDNA (cDNA clone MGC: 28230, IMAGE: 3991335). Human NUP205 subcloned from human full-length cDNA (cDNA clone MGC: 168237 IMAGE: 9020614). Human XPO5 full-length was subcloned from human full-length cDNA (cDNA clone MGC: 74566 IMAGE: 5492046). Human SMAD4 full-length was subcloned from human full-length cDNA (cDNA clone MGC: 8602 IMAGE: 2961238), human SMAD2 was subcloned from human full-length cDNA (cDNA clone MGC: 34440 IMAGE: 5221801), human SMAD5 was subcloned from human full-length cDNA (cDNA clone MGC: 8960 IMAGE:3906006). Mouse Ipo7 was subcloned from mouse full-length Importin7 (cDNA clone, MGC: 175386, IMAGE: 100014508). Expression vectors were produced using LR clonase (Invitrogen®) following the manufacturer's instruction. The following expression vectors were used in this publication: pRK5-N-Myc, pCDNA6.2-N-GFP, pCDNA6.2-C-GFP, pCS-Dest2, and pSirenRetroQ. Clones reflecting the mutations identified in individuals with SRNS were introduced in the cDNA constructed using the Quick change II XL site-directed mutagenesis kit, Agilent Technologies. This technique was also applied to generate a human SMAD4 construct lacking the canonical nuclear export signal (amino acids 142-149).45

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A